Latest News
AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research
A UNC School of Medicine research team led by Mark Zylka, PhD, and Ben Philpot, PhD, has generated preclinical evidence that gene therapy may help individuals with Angelman syndrome by improving seizure and motor outcomes.
UNC School of Medicine Ranked First for Primary Care for Third Straight Year
In the organization’s annual rankings of “America’s Best Graduate Schools,” U.S. News & World Report ranked UNC School of Medicine 1st in primary care and 23rd in research.
UNC Health Begins COVID-19 Testing at UNC Medical Center
UNC Health’s in-house testing will help ease demand on State Health Department & LabCorp.
UNC Health Enacts Heightened Restrictions for Facility Visitors, Vendors, Volunteers and Students
Community events, activities and meetings hosted at UNC Health facilities are canceled until further notice
Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.
UNC Health Announces Voluntary Visitor Restrictions for Hospitals
UNC Health Urges Use of Virtual Options.
Virtual Reality Shows Promise for Early Detection of MS Balance Problems
The UNC School of Medicine lab of Jason Franz, PhD, created virtual reality experiments to show how a potentially portable and inexpensive test could reduce falls and related injuries in people with multiple sclerosis.
Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases
Led by UNC School of Medicine neuroscientist Hyejung Won, PhD, researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association studies.
ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership
This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center.
CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA
Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel
The test will identify Duchenne muscular dystrophy and some other types of muscle conditions, as part of the Early Check Program, which is led at UNC-Chapel Hill by Cynthia Powell, MD.
Five-year survival improves for certain cancers in adolescents and young adults
UNC Lineberger's Hazel Nichols, PhD, is senior author of a report in the Journal of the National Cancer Institute that shows which cancer types saw improved outcomes among adolescents and young adults.
CAR-T therapy gives patient options after cancer returns
When Sabrina Shelton exhausted traditional treatment options, her care team at UVA referred her to UNC Lineberger’s Matthew Foster, MD, for a chimeric antigen receptor T-cell (CAR-T) therapy clinical trial. Watch the video and read the story about her journey.
UNC Health Care is now “UNC Health”
The UNC Health system introduced a new name, new logo, and new commitment to transformational change.
UNC School of Medicine NIH Funding Jumps More Than $23 Million in Federal FY 2019
All six basic science departments rank in the top 10 in National Institutes of Health funding, according to a new report by the Blue Ridge Institute for Medical Research, and 12 clinical departments rank in the top 30.
TBJ Selects Nine Health Care Heroes from UNC Medical Center, School of Medicine, and UNC REX
The winners of the 2020 Triangle Business Journal Health Care Hero Awards were honored in a ceremony on February 13.
Researchers implicate gene in DNA errors in aggressive breast cancer
Researchers led by UNC Lineberger Comprehensive Cancer Center’s Gaorav Gupta, MD, PhD, described the role of a mutation in the Mre11 gene in triple negative breast cancer and how a disruption of Mre11 function plays a significant role in the genomic instability of that cancer type.
Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds
The study led by UNC’s Jeffrey Sonis, MD, MPH, in the departments of social medicine and family medicine, finds that most of the approval processes used by medical specialty societies in the U.S. have the potential to undermine editorial independence of the guideline development committee.
A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors
Researchers from the UNC School of Medicine, UC San Francisco, and the University of Buffalo used 3-D computer simulations and pharmacological experiments to create molecules that selectively target the MT1 melatonin receptor to modulate the biological clocks in animal models of jet lag. Bryan L. Roth, MD, PhD, is co-senior author.
UNC School of Medicine Announces New Class of FIRST Scholars
The Fully Integrated Readiness for Service Training (FIRST) is a three-year medical school curriculum to fast-track UNC School of Medicine students into UNC Family Medicine Residency, followed by three years of service in NC with ongoing support in practice.